
Alcon ALC
$ 74.09
-1.04%
Annual report 2025
added 04-18-2026
Country |
|
IPO year |
2019 |
Industry |
Medical instruments |
Stock Exchange |
NYSE |
Shares |
- |
Market Cap[1] |
$ 40.4 B |
EBITDA (LTM) |
$ -252 M |
P/E (LTM) |
-56.72 |
P/S (LTM) |
5.73 |
EPS (LTM) |
-1.32 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Ekso Bionics Holdings
EKSO
|
$ 11.79 | -1.83 % | $ 28.6 M | Nasdaq Capital Market | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 120.8 | -6.47 % | $ 3.87 B | Nasdaq Global Select Market,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Repro Med Systems
KRMD
|
$ 4.07 | 2.01 % | $ 188 M | Nasdaq Capital Market | ||
|
Intuitive Surgical
ISRG
|
$ 457.78 | 0.04 % | $ 163 B | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 62.36 | -0.86 % | $ 12.4 B | NYSE,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 26.33 | 1.5 % | $ 4.42 B | NYSE | ||
|
Pulse Biosciences
PLSE
|
$ 20.83 | -1.61 % | $ 1.4 B | Nasdaq Global Select Market | ||
|
Masimo Corporation
MASI
|
$ 178.48 | 0.03 % | $ 9.51 B | Nasdaq Global Select Market,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
electroCore
ECOR
|
$ 6.64 | 2.0 % | $ 56.3 K | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 59.26 | -1.38 % | $ 2.98 B | NYSE,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 27.19 | 3.15 % | $ 1.35 B | Nasdaq Global Market,SPB | ||
|
STERIS plc
STE
|
$ 214.4 | -1.14 % | $ 21.1 B | NYSE,SPB | ||
|
ICU Medical
ICUI
|
$ 118.85 | -0.29 % | $ 2.93 B | Nasdaq Global Select Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 121.77 | -1.73 % | $ 5.43 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Glaukos Corporation
GKOS
|
$ 140.22 | -2.7 % | $ 6.79 B | NYSE,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 10.37 | 2.37 % | $ 214 M | NYSE American | ||
|
Microbot Medical
MBOT
|
$ 2.1 | 0.48 % | $ 96.2 M | Nasdaq Global Select Market | ||
|
Utah Medical Products
UTMD
|
$ 65.77 | 0.54 % | $ 213 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.34 | 9.03 % | $ 27.9 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 62.01 | -9.05 % | $ 3.67 B | Nasdaq Global Select Market,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 300.68 | 1.04 % | $ 21.7 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.81 | 0.51 % | $ 2.35 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.63 | 0.08 % | $ 18.9 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 48.36 | -3.55 % | $ 159 M | Nasdaq Global Select Market | ||
|
LeMaitre Vascular
LMAT
|
$ 112.04 | 2.09 % | $ 2.54 B | Nasdaq Global Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 21.21 | 0.62 % | $ 977 M | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.93 | 3.21 % | $ 176 M | NYSE American | ||
|
Baxter International
BAX
|
$ 17.21 | -2.1 % | $ 8.83 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 205.02 | -4.11 % | $ 29.9 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 29.02 | 3.24 % | $ 1.39 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.36 | -0.31 % | $ 282 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 11.16 | 2.01 % | $ 456 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 149.31 | 0.13 % | $ 42.9 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.11 | -1.58 % | $ 32.3 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 2.95 | -2.96 % | $ 217 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 117.2 | -0.94 % | $ 6.53 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.